Attached files
file | filename |
---|---|
EX-99.1 - CHINA SKY ONE MEDICAL, INC. | v206489_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of report (Date of earliest event reported):
|
December 21,
2010
|
CHINA
SKY ONE MEDICAL, INC.
|
(Exact
Name of Registrant as Specified in
Charter)
|
Nevada
|
001-34080
|
87-0430322
|
||
(State
or Other Jurisdiction
|
(Commission
|
(IRS
Employer
|
||
of
Incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
No.
2158, North Xiang An Road, Song Bei District,
Harbin,
People’s Republic of China 150028
|
(Address
of Principal Executive
Offices)
|
Registrant's telephone number, including area code:
|
86-451-87032617
(China)
|
(Former
Name or Former Address, if Changed Since Last
Report)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
1.01.
|
Entry
into a Material Definitive
Agreement.
|
On December 21, 2010, Harbin Tian Di
Ren Medical Science and Technology Company (“TDR”), a subsidiary of China Sky
One Medical, Inc., a Nevada corporation (the “Company”), entered into an
agreement (the “Agreement”) with Heilongjiang Tang Wang He Forest Bureau,
pursuant to which the Company acquired the rights to grow and harvest herbs and
other plants on approximately 30,000 hectares (approximately 74,000 acres) of
forest land in the Xiao Xing’an Mountain region in Heilongjiang Province, China,
for a 30-year term expiring December 20, 2040. Pursuant to the
Agreement, the Company may utilize the herbs and other plants it grows on the
forest land as raw materials in connection with the production of the Company’s
products, as well as sell such herbs and other plants to third
parties. The Company’s total rent for the 30-year term is
approximately $36 million (RMB 240 million), which is after an
approximately $4.5 million (RMB 30 million) discount the Company received by
paying the full amount upon execution of the Agreement.
A copy of
the press release further discussing this matter is furnished as Exhibit 99.1,
and is incorporated herein by reference.
Item
2.03.
|
Creation
of a Direct Financial Obligation or an Obligation under an Off-Balance
Sheet Arrangement of a Registrant.
|
Reference
is made to the disclosure in Item 1.01 above, which disclosure is incorporated
herein by reference.
Item
9.01.
|
Financial
Statements and Exhibits.
|
(d) Exhibits.
The
exhibits listed in the following Exhibit Index are filed as part of this Form
8-K.
Exhibit
No.
|
Description
|
|
99.1
|
Press
Release, dated December 27,
2010
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
CHINA SKY ONE MEDICAL,
INC.
|
||
(Registrant)
|
||
Date: December 27, 2010
|
By:
|
/s/ Liu Yan-qing
|
Liu
Yan-qing
|
||
Chairman,
Chief Executive Officer and
President
|